Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cerus Corp (CERS)

Cerus Corp (CERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 653,462
  • Shares Outstanding, K 177,090
  • Annual Sales, $ 159,520 K
  • Annual Income, $ -54,380 K
  • 60-Month Beta 1.14
  • Price/Sales 4.64
  • Price/Cash Flow N/A
  • Price/Book 7.91
Trade CERS with:

Options Overview Details

View History
  • Implied Volatility 53.36% ( -5.39%)
  • Historical Volatility 47.67%
  • IV Percentile 25%
  • IV Rank 10.30%
  • IV High 231.87% on 09/07/22
  • IV Low 32.85% on 03/08/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 103
  • Put/Call OI Ratio 1.10
  • Today's Open Interest 21,743
  • Open Int (30-Day) 21,500

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.39 +3.54%
on 09/27/22
4.32 -18.66%
on 09/12/22
-0.68 (-16.23%)
since 08/29/22
3-Month
3.39 +3.54%
on 09/27/22
5.95 -41.01%
on 07/08/22
-1.83 (-34.27%)
since 06/29/22
52-Week
3.39 +3.54%
on 09/27/22
8.06 -56.42%
on 11/05/21
-2.58 (-42.36%)
since 09/29/21

Most Recent Stories

More News
Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting

Cerus Corporation (Nasdaq:CERS) today announced a selection of abstracts and an industry workshop at the 2022 AABB Annual Meeting, taking place in Orlando, FL from October 1 through October 4. This year’s...

CERS : 3.52 (-4.61%)
After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for Cerus (CERS)

Cerus (CERS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings...

CERS : 3.52 (-4.61%)
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Sector ETF report for XHE

XHE : 85.71 (-1.41%)
VIVO : 31.87 (-0.09%)
CYRX : 24.11 (-2.70%)
CERS : 3.52 (-4.61%)
IHI : 47.69 (-0.75%)
MDEV : 16.59 (+2.69%)
Zimmer (ZBH) Surges 4.2%: Is This an Indication of Further Gains?

Zimmer (ZBH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ZBH : 106.62 (-0.85%)
CERS : 3.52 (-4.61%)
Down 20.4% in 4 Weeks, Here's Why Cerus (CERS) Looks Ripe for a Turnaround

Cerus (CERS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could...

CERS : 3.52 (-4.61%)
Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks

This billionaire-guided hedge fund went bargain-shopping in the second quarter.

AFMD : 2.04 (-4.46%)
CERS : 3.52 (-4.61%)
REPL : 16.40 (-5.42%)
Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public Health Emergency

Cerus Corporation (Nasdaq: CERS) acknowledges the U.S. Department of Health and Human Services’ declaration of monkeypox as a national Public Health Emergency. Currently, more than 10,000 cases of monkeypox...

CERS : 3.52 (-4.61%)
Cerus (CERS) Q2 2022 Earnings Call Transcript

CERS earnings call for the period ending June 30, 2022.

CERS : 3.52 (-4.61%)
Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates

Cerus (CERS) delivered earnings and revenue surprises of 16.67% and 2.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CERS : 3.52 (-4.61%)
QIPT : 4.07 (-3.10%)
Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range

Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2022.

CERS : 3.52 (-4.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

3rd Resistance Point 4.02
2nd Resistance Point 3.87
1st Resistance Point 3.78
Last Price 3.52
1st Support Level 3.54
2nd Support Level 3.39
3rd Support Level 3.30

See More

52-Week High 8.06
Fibonacci 61.8% 6.27
Fibonacci 50% 5.72
Fibonacci 38.2% 5.17
Last Price 3.52
52-Week Low 3.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar